drug · small molecule
omacetaxine mepesuccinate
Marketedupdated 6mo agoby $TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD🔗 ChEMBL
Approvedcommunity read0 votes
Small molecule drug with a maximum clinical stage of Approval (across all indications), with an approval for neoplasm and chronic myelogenous leukemia and 7 investigational indications.
all catalysts(0)
nothing on the calendar yet
Patent cliff
source: FDA Orange Bookpatents (1)
- Oct 26, 2026method-of-use (U-1300)US 6987103
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 8h ago
Found something off?
comments(0)
5-min edit window · permanent after that